Patents by Inventor Michael Muehlebach

Michael Muehlebach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8802151
    Abstract: The instant invention relates to shaped transition metal particles, in particular in the form of a dispersion in an aqueous and/or organic medium, the manufacture thereof and their use as an infrared (IR) absorbing agent, an IR curing agent for coatings, an additive in conductive formulations, an antimicrobial agent or for sensoring organic and/or inorganic compounds. Further, the invention relates to dispersions comprising said shaped particles and an aqueous and/or organic medium, such as a thermoplastic or crosslinkable polymer, as well as to antimicrobial compositions and products.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: August 12, 2014
    Assignee: BASF SE
    Inventors: Nikolay A. Grigorenko, Michael Muehlebach, Florian Muehlebach
  • Publication number: 20120283336
    Abstract: The instant invention relates to shaped transition metal particles, in particular in the form of a dispersion in an aqueous and/or organic medium, the manufacture thereof and their use as an infrared (IR) absorbing agent, an IR curing agent for coatings, an additive in conductive formulations, an antimicrobial agent or for sensoring organic and/or inorganic compounds. Further, the invention relates to dispersions comprising said shaped particles and an aqueous and/or organic medium, such as a thermoplastic or crosslinkable polymer, as well as to antimicrobial compositions and products.
    Type: Application
    Filed: March 17, 2010
    Publication date: November 8, 2012
    Applicant: BASF SE
    Inventors: Nikolay A. Grigorenko, Andreas Muehlebach, Michael Muehlebach, Florian Muehlebach
  • Publication number: 20120142850
    Abstract: The present invention provides organic-inorganic composite particles having an average diameter of 60 to 12,000 nm, wherein the organic-inorganic composite particles are obtainable by reacting particles A, which are particles carrying at least one functional group Ra, with particles B, which are particles carrying at least one functional group Rb, under formation of a covalent linkage between particles A and particles B. The present invention also provides compositions comprising these particles and substrates coated with these compositions.
    Type: Application
    Filed: April 26, 2010
    Publication date: June 7, 2012
    Applicant: BASF SE
    Inventors: Andreas Mühlebach, Michael Mühlebach, Florian Mühlebach, François Rime, Wolfgang Peter, Karin Powell
  • Patent number: 7727522
    Abstract: The invention relates to retroviral vectors (known as lentiviral vectors), which are used to transfer genes into cells that are at cell cycle stage G0, to methods for their production and to the use thereof for transferring genes into mammalian cells. Said vectors are derived from SIVsmmPBj14 (simian immunodeficiency virus) of the sooty mangabey monkey, strain PBj 14.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: June 1, 2010
    Inventors: Klaus Cichutek, Michael Muehlebach, Matthias Schweizer
  • Patent number: 7601743
    Abstract: Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts and all stereoisomers and tautomeric forms of the compounds of formula I can be used as agrochemical active ingredients and can be prepared in a manner known per se.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: October 13, 2009
    Assignee: Syngenta Crop Protection, Inc.
    Inventors: Andre Jeanguenat, Anthony O'Sullivan, Michael Muehlebach, Stephan Trah, Roger Graham Hall
  • Publication number: 20050202560
    Abstract: The invention relates to retroviral vectors (known as lentiviral vectors), which are used to transfer genes into cells that are at cell cycle stage G0, to methods for their production and to the use thereof for transferring genes into mammalian cells. Said vectors are derived from SIVsmmPBj14 (simian immunodeficiency virus) of the sooty mangabey monkey, strain PBj 14.
    Type: Application
    Filed: April 3, 2003
    Publication date: September 15, 2005
    Inventors: Klaus Cichutek, Michael Muehlebach, Matthias Schweizer